A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1
- PMID: 31575857
- PMCID: PMC6773777
- DOI: 10.1038/s41408-019-0244-2
A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures

Similar articles
-
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.Ann Hematol. 2018 Oct;97(10):1757-1765. doi: 10.1007/s00277-018-3373-y. Epub 2018 May 22. Ann Hematol. 2018. PMID: 29785446
-
Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing.Mol Diagn Ther. 2019 Dec;23(6):791-802. doi: 10.1007/s40291-019-00436-8. Mol Diagn Ther. 2019. PMID: 31673932
-
Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.Cytometry B Clin Cytom. 2019 Jan;96(1):67-72. doi: 10.1002/cyto.b.21744. Epub 2018 Nov 12. Cytometry B Clin Cytom. 2019. PMID: 30417521
-
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.Int J Mol Sci. 2018 Nov 6;19(11):3492. doi: 10.3390/ijms19113492. Int J Mol Sci. 2018. PMID: 30404199 Free PMC article. Review.
-
Measurable residual disease testing for personalized treatment of acute myeloid leukemia.APMIS. 2019 May;127(5):337-351. doi: 10.1111/apm.12926. Epub 2019 Mar 28. APMIS. 2019. PMID: 30919505 Review.
Cited by
-
Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects.Blood Adv. 2020 Dec 8;4(23):6077-6085. doi: 10.1182/bloodadvances.2020002997. Blood Adv. 2020. PMID: 33290546 Free PMC article. Review.
-
Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1.Leuk Lymphoma. 2020 Dec;61(13):3154-3160. doi: 10.1080/10428194.2020.1798951. Epub 2020 Aug 5. Leuk Lymphoma. 2020. PMID: 32757686 Free PMC article.
-
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML).Leukemia. 2021 May;35(5):1392-1404. doi: 10.1038/s41375-021-01131-6. Epub 2021 Feb 8. Leukemia. 2021. PMID: 33558666 Free PMC article.
-
Liquid biopsies and minimal residual disease in myeloid malignancies.Front Oncol. 2023 May 5;13:1164017. doi: 10.3389/fonc.2023.1164017. eCollection 2023. Front Oncol. 2023. PMID: 37213280 Free PMC article. Review.
-
How artificial intelligence might disrupt diagnostics in hematology in the near future.Oncogene. 2021 Jun;40(25):4271-4280. doi: 10.1038/s41388-021-01861-y. Epub 2021 Jun 8. Oncogene. 2021. PMID: 34103684 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical